Brokerages Set Cigna Group (NYSE:CI) PT at $339.45

Posted by Geri Gentry on Sep 8th, 2026

Shares of Cigna Group (NYSE:CI – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-two brokerages that are presently covering the stock, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $339.45.

A number of research analysts have commented on CI shares. UBS Group upped their price target on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Guggenheim lifted their price objective on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Barclays boosted their price objective on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research note on Thursday, August 27th. Finally, Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, August 29th.

Read Our Latest Report on Cigna Group

Cigna Group Price Performance

Cigna Group stock opened at $282.24 on Friday. The company’s 50 day simple moving average is $283.56 and its 200-day simple moving average is $280.94. The company has a market capitalization of $74.58 billion, a price-to-earnings ratio of 11.68, a price-to-earnings-growth ratio of 0.97 and a beta of 0.31. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76.

Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the prior year, the business posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities research analysts expect that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio is currently 25.82%.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 23,012 shares of company stock valued at $6,386,550. Insiders own 0.60% of the company’s stock.

Institutional Trading of Cigna Group

Several hedge funds have recently modified their holdings of CI. Wilkerson Advisory Group LLC purchased a new stake in shares of Cigna Group during the 4th quarter worth $25,000. Osbon Capital Management LLC purchased a new position in Cigna Group in the second quarter valued at $26,000. Cedar Mountain Advisors LLC raised its stake in Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after buying an additional 68 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in Cigna Group in the second quarter valued at $29,000. Finally, Fiduciary Financial Advisors purchased a new stake in Cigna Group during the 2nd quarter worth about $29,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

About Cigna Group

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.